Bryce Heitman
Family Medicine · Emporia, KSNPI 1336325646
Payments from drug & device makers
Across 127 payments — averaging $15.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$319
- Novo Nordisk$230
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$171
- Merck$147
- AstraZeneca$138
- Pfizer$116
- plus $829 from 22 others
What the payments were for
- Food & beverage$1,950100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 18 | $319 |
| Novo Nordisk | 16 | $230 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 11 | $171 |
| Merck | 11 | $147 |
| AstraZeneca | 9 | $138 |
| Pfizer | 7 | $116 |
| Lilly USA, LLC | 8 | $115 |
| Boehringer Ingelheim | 7 | $113 |
| Sanofi-aventis U.S. LLC | 6 | $82 |
| Amgen | 5 | $69 |
| Otsuka America Pharmaceutical, Inc. | 2 | $51 |
| Bayer | 3 | $49 |
| Novartis | 3 | $45 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $42 |
| GSK | 3 | $37 |
| Teva Pharmaceuticals USA, Inc. | 2 | $30 |
| Tris Pharma Inc | 2 | $28 |
| Dexcom, Inc. | 1 | $19 |
| Smith+Nephew | 1 | $19 |
| E.r. Squibb & Sons, L.L.C. | 1 | $17 |
| Abbott | 1 | $16 |
| Ardelyx, Inc. | 1 | $15 |
| Ultragenyx Pharmaceutical Inc. | 1 | $15 |
| Insulet Corporation | 1 | $15 |
| Idorsia Pharmaceuticals US Inc | 1 | $13 |
| Boston Scientific | 1 | $13 |
| Agios Pharmaceuticals, Inc. | 1 | $13 |
| Sanofi Pasteur Inc. | 1 | $12 |
How this compares
$1,950 in reported general payments places this provider in the 70th percentile of 1,469 family medicine providers in Kansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 141 | $109,452 |
| JardianceEmpagliflozin | 111 | $90,101 |
| OzempicSemaglutide | 62 | $58,049 |
| MounjaroTirzepatide | 34 | $38,268 |
| XifaxanRifaximin | 12 | $36,004 |
| Tresiba Flextouch U-100Insulin Degludec | 28 | $29,737 |
| MyrbetriqMirabegron | 43 | $22,353 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 48 | $21,888 |
| XareltoRivaroxaban | 34 | $18,988 |
| JanuviaSitagliptin Phosphate | 44 | $18,945 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 30 | $18,275 |
| TrulicityDulaglutide | 17 | $18,207 |
| ErythromycinErythromycin Base | 15 | $16,665 |
| FarxigaDapagliflozin Propanediol | 18 | $15,122 |
| WegovySemaglutide | 11 | $14,132 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $116 | $109,452141 claims |
| Boehringer IngelheimJardiance | $113 | $90,101111 claims |
| Novo NordiskOzempic, Wegovy | $230 | $72,18173 claims |
| Lilly USA, LLCMounjaro, Trulicity, Olanzapine | $115 | $59,43571 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan | $171 | $36,00412 claims |
| MerckJanuvia | $147 | $18,94544 claims |
| AstraZenecaFarxiga, Symbicort | $138 | $18,30232 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $37 | $15,94828 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,469 family medicine providers in Kansas.
Other family medicine in Emporia
- Terry PolingWichita$24.2M
- Richard GloverNewton$19.6M
- Daniel DickersonLenexa$13.6M
- Patrick YaoOlathe$11.7M
- Michael RauschAugusta$8.1M
- Terry KleinWichita$5.9M
- Richard EgelhofWichita$4.1M
- Thomas KleinWichita$3.4M
- Troy HoldemanNewton$3.2M
- Stacy SlechtaNewton$3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.